<p>Inflammatory infiltrate score—SDG exhibited more leukocytes than other groups through to Day 10.</p
<p>The results of leukocyte (A), neutrophil (B), lymphocyte (C) and monocyte (D) counts according to...
<p>Levels of inflammatory markers in diacerein and placebo groups at baseline and end of trial.</p
<p>(A) An MTT assay showing relative proliferation of Nor MSCs, exposed to 24 hours of IFNγ and/or T...
<p>(A) Representative picture depicting adherence of PKH26 labelled leukocytes to human umbilical ve...
<p>(A) eosinophil counts in BALF. (B) Total cell counts in BALF. (C) Lymphocyte counts in BALF. (D) ...
<p>Levels of inflammatory markers as a function of the interaction between personality and deprivati...
<p>(A) The total number of leucocytes and the percentages of lymphocytes in patients during disease ...
<p>Log<sub>2</sub> of the cytokine concentration normalized on the total amount of protein in plasma...
<p>Concentrations of inflammatory markers in Hemovac drainage fluid fromeach TKA cohort.</p
<p>Distribution of inflammatory markers according to CD4 T cell count at ART initiation.</p
<p>G1 to G5 groups are as indicated in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>Data represent mean ± SEM, <i>n</i> = 4–10. N (naïve); Ar. (arthritic). <sup>*</sup><i>P</i><0.05...
<p>(A) Scheme of the 45-day HDBR of -6° and the time of sample collections. (B) Changes of T cell-d...
<p>Data are expressed as mean ±SD neutrophil count. <b>O</b> (p<0.05) compared between the neighbori...
<p>PMN: polymorphonuclear cells. ML: mononuclear leukocytes. Hpf: high power field. Scoring scheme a...
<p>The results of leukocyte (A), neutrophil (B), lymphocyte (C) and monocyte (D) counts according to...
<p>Levels of inflammatory markers in diacerein and placebo groups at baseline and end of trial.</p
<p>(A) An MTT assay showing relative proliferation of Nor MSCs, exposed to 24 hours of IFNγ and/or T...
<p>(A) Representative picture depicting adherence of PKH26 labelled leukocytes to human umbilical ve...
<p>(A) eosinophil counts in BALF. (B) Total cell counts in BALF. (C) Lymphocyte counts in BALF. (D) ...
<p>Levels of inflammatory markers as a function of the interaction between personality and deprivati...
<p>(A) The total number of leucocytes and the percentages of lymphocytes in patients during disease ...
<p>Log<sub>2</sub> of the cytokine concentration normalized on the total amount of protein in plasma...
<p>Concentrations of inflammatory markers in Hemovac drainage fluid fromeach TKA cohort.</p
<p>Distribution of inflammatory markers according to CD4 T cell count at ART initiation.</p
<p>G1 to G5 groups are as indicated in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>Data represent mean ± SEM, <i>n</i> = 4–10. N (naïve); Ar. (arthritic). <sup>*</sup><i>P</i><0.05...
<p>(A) Scheme of the 45-day HDBR of -6° and the time of sample collections. (B) Changes of T cell-d...
<p>Data are expressed as mean ±SD neutrophil count. <b>O</b> (p<0.05) compared between the neighbori...
<p>PMN: polymorphonuclear cells. ML: mononuclear leukocytes. Hpf: high power field. Scoring scheme a...
<p>The results of leukocyte (A), neutrophil (B), lymphocyte (C) and monocyte (D) counts according to...
<p>Levels of inflammatory markers in diacerein and placebo groups at baseline and end of trial.</p
<p>(A) An MTT assay showing relative proliferation of Nor MSCs, exposed to 24 hours of IFNγ and/or T...